Table II.

Independent risk factors for the prognosis of LUSC patients.

	Univariate analysis		Multivariate analysis
Factor	HR (95% CI)	P-value	HR (95% CI)	P-value
miR-590	1.647	0.009	2.152	0.004
(low vs. high)	(1.122–2.896)		(1.285–3.233)
Age	1.014	0.062
(>60 vs. ≤60)	(0.999–1.029)
Sex	0.819	0.788
(male vs. female)	(0.277–2.424)
Pathological staging	2.143	0.013	1.268	0.113
(low vs. high/medium differentiation)	(1.288–2.715)		(0.918–2.471)
Maximum diameter of tumor	0.812	0.682
(>50 mm vs. ≤50 mm)	(0.357–1.847)
Lymph node metastasis	3.064	0.012	1.097	0.013
(positive vs. negative)	(1.282–7.323)		(0.336–3.582)
Distant metastasis	2.124	0.001	1.984	0.005
(positive vs. negative)	(1.557–4.575)		(1.137–3.754)
TNM staging	2.112
(III/IV vs. I/II)	(1.231–3.625)	0.036

LUSC, lung squamous cell carcinoma; HR, hazard ratio; CI, confidence interval; miR-590, micro ribonucleic acid-590; TNM, tumor, node and metastasis.